AKT1 and head and neck squamous cell carcinoma: Another study discovered significant differences in the expression of EGFR/PI3K/Akt/mTOR signaling-related proteins and clinical prognosis in patients with HPV16-positive or HPV16-negative head and neck squamous cell carcinoma (HNSCC) (11).